Peak Pharmaceuticals, Inc. (PKPH) Research

Peak Pharmaceuticals, Inc., an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions. Originally established in 2007 as Cannabis Therapy Corporation, the company rebranded to Peak Pharmaceuticals, Inc. in December 2014 and maintains its main office in Scottsdale, Arizona.

Market snapshot

Symbol
PKPH
Price
$1.55
Day change
0.00%
Market cap
$607.3K
52-week range
1.35-43.8
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Atlantic Energy Solutions, Inc. (AESO)
  • Banco Espírito Santo, S.A. (BKESY)
  • China Teletech Holding, Inc. (CNCT)
  • Kemiao Garment Holding Group (KMGH)
  • My City Builders, Inc. (MYCB)
  • Nodechain, Inc. (NODC)
  • Quantum FinTech Acquisition Corporation (QFTA)
  • R&Q Insurance Holdings Ltd. (RQIHF)

Open Peak Pharmaceuticals, Inc. (PKPH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.